Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

Inspire Medical Systems (INSP) Stock Forecast & Price Target

→ Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad)
Free insp Stock Alerts
$152.55
-2.67 (-1.72%)
(As of 01:39 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Inspire Medical Systems - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 16 Analyst Ratings

Consensus Price Target

$256.53
68.16% Upside
High Forecast$371.00
Average Forecast$256.53
Low Forecast$159.00
TypeCurrent Forecast
5/21/23 to 5/20/24		1 Month Ago
4/21/23 to 4/20/24		3 Months Ago
2/20/23 to 2/20/24		1 Year Ago
5/21/22 to 5/21/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
11 Buy rating(s)
10 Buy rating(s)
8 Buy rating(s)
8 Buy rating(s)
Hold
5 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$256.53$272.20$272.92$312.56
Forecasted Upside68.16% Upside22.69% Upside21.65% Upside25.10% Upside

INSP Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

INSP Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Inspire Medical Systems Stock vs. The Competition

TypeInspire Medical SystemsMedical CompaniesS&P 500
Consensus Rating Score
2.69
2.69
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside65.27% Upside651.89% Upside7.85% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Forecasts and Stock Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/8/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetOverweight ➝ Overweight$250.00 ➝ $255.00+3.72%
5/8/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeBuy ➝ Neutral$265.00 ➝ $225.00-8.49%
4/19/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$285.00+18.20%
3/27/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$250.00+17.18%
3/20/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$280.00+48.64%
3/19/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOverweight$250.00+25.48%
Everybody laughed when he recommended Netflix (Ad)

"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined.

Click here to see how it could become the No. 1 investment of the next decade.
2/6/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOverweight$278.00+28.57%
1/19/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageBuy$245.00+26.70%
1/2/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Hold$210.00+3.23%
12/13/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeOverweight ➝ Equal Weight$245.00 ➝ $187.00+4.98%
10/17/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOverweight ➝ Overweight$340.00 ➝ $181.00+14.23%
10/16/2023Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating		M. Kratky
Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated RatingMarket Perform
10/16/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageMarket Perform$159.00+5.92%
9/6/2023UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy ➝ Buy$405.00 ➝ $322.00+37.43%
8/2/2023Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Boost TargetBuy ➝ Buy$305.00 ➝ $350.00+22.64%
7/18/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$371.00+15.21%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:59 PM ET.

INSP Frequently Asked Questions

What is Inspire Medical Systems's stock forecast and purchase recommendation?

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Inspire Medical Systems is $256.53, with a high forecast of $371.00 and a low forecast of $159.00. The consensus rating for Inspire Medical Systems stock is Moderate Buy based on the current 5 hold ratings and 11 buy ratings for INSP. Learn more on INSP's analyst rating history.

Do Wall Street analysts like Inspire Medical Systems more than its competitors?

Analysts like Inspire Medical Systems less than other "medical" companies. The consensus rating score for Inspire Medical Systems is 2.69 while the average consensus rating score for "medical" companies is 2.69. Learn more on how INSP compares to other companies.

Is Inspire Medical Systems being downgraded by Wall Street analysts?

Over the previous 90 days, Inspire Medical Systems's stock had 1 downgrade by analysts.

Does Inspire Medical Systems's stock price have much upside?

According to analysts, Inspire Medical Systems's stock has a predicted upside of 17.49% based on their 12-month stock forecasts.

What analysts cover Inspire Medical Systems?

Inspire Medical Systems has been rated by research analysts at Bank of America, Mizuho, Morgan Stanley, Piper Sandler, Royal Bank of Canada, and Truist Financial in the past 90 days.


Stock Forecasts and Research Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NYSE:INSP) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Does this make you sick?
Allegiance Gold
Dems have chosen Biden replacement?
Paradigm Press
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts
This Could be Your “Big Money” AI Moment
InvestorPlace
Digitizing the $11T commodities sector with one tiny stock
Resource Stock Digest